TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis

Journal of Leukocyte Biology

Volumn 69, Issue 6, 2001, Pages 928-936

  Dias, A A M ^a   Goodman, A R ^a   Dos Santos, J L ^a   Gomes, R N ^a   Altmeyer, A ^a   Bozza, P T ^a   Horta, M D F ^a   Vilcek, J ^a   Reis, L F L ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

Endotoxin; Inflammation; Lipopolysaccharide; Nitric oxide; TNF

Indexed keywords

AMYLOID P COMPONENT; C REACTIVE PROTEIN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PENTRAXIN 3; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTOXEMIA; GENE OVEREXPRESSION; LIGATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SEQUENCE HOMOLOGY; SURVIVAL; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, OUTBRED STRAINS; C-REACTIVE PROTEIN; CECUM; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; INTERFERON TYPE II; INTESTINAL PERFORATION; LIGATION; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, TRANSGENIC; NITRIC OXIDE; RECOMBINANT FUSION PROTEINS; SEPSIS; SERUM AMYLOID P-COMPONENT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034976879     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (60)

1. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts
2. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component
3. Promoter structure and transcriptional activation of the murine TSG-14 gene encoding a tumor necrosis factor/interleukin-1-inducible pentraxin protein
4. Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites
5. TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins
6. Characterization of C-reactive protein and the complement subcomponent Clt as homologous proteins displaying cyclic pentameric symmetry (pentraxins)
7. Long pentraxins: An emerging group of proteins with diverse functions
8. Identification of a novel member of the pentraxin family in Xenopus laevis
9. Apexin, an acrosomal pentaxin
10. The sperm acrosomal matrix contains a novel member of the pentaxin family of calcium-dependent binding proteins
11. Neuronal pentraxin, a secreted protein with homology to acute phase proteins of the immune system
12. Neuronal pentraxin receptor, a novel putative integral membrane pentraxin that interacts with neuronal pentraxin 1 and 2 and taipoxin-associated calcium-binding protein 49
13. Human neuronal pentraxin II (NPTX2): Conservation, genomic structure, and chromosomal localization
14. Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity
15. Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA)
16. Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes
17. Relationship of TSG-14 protein to the pentraxin family of major acute phase proteins
18. Expression of a long pentraxin, PTX3, by monocytes exposed to the mycobacterial cell wall component lipoarabinomannan
19. Interferon-gamma inhibits expression of the long pentraxin PTX3 in human monocytes
20. Differential regulation of TSG-14 expression in murine fibroblasts and peritoneal macrophages
21. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component
22. Simplified mammalian DNA isolation procedure
23. Genomic sequencing
24. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family
25. Nonparametric estimation from incomplete observations
26. Studies of peripheral glucose uptake during sepsis
27. Nitric oxide: A cytotoxic activated macrophage effector molecule
28. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
29. Sepsis and septic shock - A review of laboratory models and a proposal
30. Antigen-presenting function of the macrophage
31. TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms
32. Cytokines as mediators in the pathogenesis of septic shock
33. Sepsis and its complications: Clinical definitions and therapeutic prospects
34. Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia
35. C-reactive protein: Structural biology and host defense function
36. Interleukin 10 protects mice from lethal endotoxemia
37. Interleukin 10 reduces mortality from severe peritonitis in mice
38. Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia
39. IL-10
40. Prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factor
41. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis
42. Impaired mast cell-dependent natural immunity in complement C3-deficient mice
43. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity
44. Induction of inflammatory, cytokine release from cultured human monocytes by C-reactive protein
45. C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages
46. Antiinflammatory properties of hepatic acute phase proteins: Preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells
47. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens
48. Nitric oxide and macrophage function
49. Inducible nitric oxide synthase: What difference does it make?
50. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
51. Altered immune responses in mice lacking inducible nitric oxide synthase
52. Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice
53. Lessons learned from nitric oxide synthase knockout animals
54. Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase
55. Deletion of endothelial nitric oxide synthase exacerbates myocardial stunning in an isolated mouse heart model
56. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury
57. Nitric oxide decreases endothelial activation by rat experimental severe pancreatitis-associated ascitic fluids
58. Nitric oxide enhances expression and shedding of tumor necrosis factor receptor I (p55) in endothelial cells
59. Activation of tumor necrosis factor-alpha-converting enzyme-mediated ectodomain shedding by nitric oxide
60. Protection against TNF-induced lethal shock by soluble guanylate cyclase inhibition requires functional inducible nitric oxide synthase